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The control of multidrug-resistant (MDR) bacteria is a growing public health problem, and new strategies are
urgently needed for the control of the infections caused by these microorganisms. Notoriously, some MDR mi-
croorganisms generate complex structures or biofilms, which adhere to surfaces and confer extraordinary resis-
tance properties that are fundamental challenges to control infections. One of the promising strategies for the
control of MDR bacteria is antimicrobial photodynamic therapy (aPDT), which takes advantage of suitable
photosensitizers (PS), oxygen and radiation to eradicate microorganisms by the generation of highly reactive
species, including reactive oxygen species (ROS) that cause cytotoxic damage and cell death. Habitual aPDT
treatments use only methylene blue (MB), but MDR microorganism eradication is not completely achieved. The
key result of this study revealed that a combination of two known PSs, 6-carboxypterin (Cap, 100 μM) and MB
(2.5–10 μM) exposed to ultraviolet and visible radiation, presents a synergistic effect on the eradication of a MDR
Klebsiella pneumoniae strain. Similar effect was observed when the treatment was performed either with plank-
tonic or biofilm growing cells. Moreover, it was found that after treatment the killing action continues in the
absence of irradiation leading to the eradication of the microorganisms growing in biofilm. Therefore, the
combined aPDT represents a promising strategy for the management of clinical contact surfaces, disinfection of
surgical instruments, biofouling and even antimicrobial wastewater treatment.1. Introduction
In the last years conventional antimicrobial therapies have been
failing due to (i) the emergence of microbial resistance to antibiotics,
known as multidrug resistance (MDR) and/or (ii) the ability of bacteria to
form biofilms that avoid conventional antimicrobial action [1], causing
serious infections called biofilm-associated persistent infections (BAPI).
Therefore, the development of new strategies to eliminate this kind of
microorganisms is urgent [2]. Antimicrobial Photodynamic Therapy
(aPDT) emerges as a new methodology in the fight against persistent
infections.
Antimicrobial photodynamic therapy is a minimally invasive tech-
nique based on a photochemical process in which a non-toxic photo-
sensitizer (PS) can be activated by low doses of radiation of a specific. Lorente), agminan@inifta.unlp.e
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is an open access article under twavelength [3, 4]. The absorbed energy generates excited states of the PS
which participates in electron-transfer reactions, generating radicals on
biomolecules and reactive oxygen species (ROS), such as superoxide
anion and hydroxyl radicals (Type I reactions) or singlet oxygen (1O2,
type II reactions). These reactive species are cytotoxic and damage
cellular components, such as proteins, nucleic acids, and phospholipids
(membranes) [5]. In consequence, bacterial cells are affected by
“photodynamic action” caused by aPDT. Moreover, after the treatment,
the elimination of microorganisms and its virulence factors occurs with
no significant side effects for the host [6].
The selection of PSs is the key point to get successful results in the
aPDT treatment. Normally, an efficient PS must have high absorption
coefficient in the whole excitation wavelength range and high triplet
state quantum yields. The triplet excited state must have high energy anddu.ar (A. Mi~nan).
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Figure 1. Molecular structures and absorption spectra of Cap and MB.
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door conditions are necessary, where sun is the cheapest source of ra-
diation. Efficient PSs with absorption ranges within the solar spectrum
could be used for sterilization of surfaces, water, etc., in outside areas.
A widely used PS is methylene-blue (MB, 3,7-bis(dimethylamino)-
phenothiazin-5-ium chloride), which under light activation may act as
a strong oxidizer to destroy targeted cells through cellular damage,
alteration of membrane permeability, and protein inactivation [7, 8]. The
wavelength range for MB photodynamic action is in the orange-yellow
wavelength range (550–700 nm), with maximum molar absorptivity of
85,000 M1 cm1 at 660 nm, and with a quantum yield for triplet excited
states formation of 0.52, and for singlet oxygen production about 0.5 [9].
Under radiation, MB shows bactericidal effects against both
Gram-positive and Gram-negative bacteria [10, 11]. The low cost and
availability of MB, as well as the possibility of using non-laser poly-
chromatic radiation sources, makes it a suitable PS that can be used in
underserved populations for the treatment of a variety of diseases [9].
Pterins are heterocyclic compounds widespread in living systems,
which participate in relevant biological processes, such as metabolic
redox reactions, and can photoinduce the oxidation of biomolecules
through both type I and type II mechanisms [12]. The excitation
wavelength range for pterins is in the UV-A (300–400 nm), with
maximum molar absorptivity of ~7,000 M1 cm1 at ~ 350 nm and a
quantum yield for triplet excited states between 0.2-0.5, depending on
the given pterin derivative [13]. It was previously demonstrated that
pterin derivatives can be efficiently used as PS. Particularly, the
photodynamic action of 6-carboxypterin (2-amino-4--
hydroxypteridine-6-carboxylic acid, Cap), was tested under artificial
UV-A radiation and sunlight exposure, proving to be efficient for the
elimination of planktonic bacteria in drinking water and in preventing
the growth of Staphylococcus aureus biofilms [14]. The corresponding
quantum yield of singlet oxygen production for Cap is about 0.3, in the
experimental conditions [13].
In this work, we have used a Klebsiella pneumoniae MDR strain, since
represents a serious cause of healthcare related infections, including
septic shock and mortality [15]. This bacteria is an opportunistic Gram
negative pathogen, responsible of several diseases, and is extremely
resistant to antibiotic treatments due to their capacity to generate bio-
films [16]. Moreover, K. pneumoniae has been found as contaminating
microorganism in roll boards, anesthesia equipment, doors, nurses area,
beds, IV pumps and pole and floors in operating rooms (ORs) and/or
intensive care units (ICUs) [17]. Frequently, the removal of
K. pneumoniae is very difficult, even sometimes impossible. Thus, the
development of new strategies to eliminate them is urgent since, as
K. pneumoniae, there are many MDR-microrganims and BAPI represents a
serious healthcare problem.
The aim of the present work was to develop an aPDT based in the
combination of two PSs able to eradicate MDR K. pneumoniae biofilms
under ultraviolet and visible artificial radiation (denoted UV þ Vis
hereinafter). Cap and MB were chosen as PSs because of their excellent
individual photodynamic inactivation properties, and more important,
due to their complementary wavelengths range of absorption
(Figure 1), which improves the efficiency in the use of polychromatic
radiation. Finally, the combined aPDT proposed in this work could be
applied to clinical contact surfaces, disinfection of surgical instruments,
biofouling and even for the antimicrobial treatment of wastewater. To
the best of our knowledge, it is the first time that aPDT combining Cap
and MB was used to eradicate pathogenic planktonic bacteria and
biofilms.
2. Materials and methods
2.1. Materials
Methylene Blue (MB, purity >90%) from Sigma Aldrich; pterin (Ptr,
purity>99%) pterin-6-carboxylic acid (Cap, purity>99%) from Schircks2
Laboratories, Switzerland. Acetonitrile (ACN) and ammonium acetate
(NH4Ac) were purchased from J. T. Baker. Aqueous solutions were pre-
pared with MilliQ water (~10 MΩ cm resistivity purified in a Milli Q
Reagent Water System apparatus) and the pH was adjusted by adding
drops of HCl and NaOH solutions from a micropipette using a pH-meter
sensION pH31 GLP combined with microelectrode XC161 (Radiometer
Analytical). Nutrient Broth (NB) (Britania, Argentina) containing pluri-
peptone (5.0 g/l), meat extract (3.0 g/l) at a final pH 6.9; and Nutrient
Agar (Britania, Argentina) containing pluripeptone (5.0 g/l), meat
extract (3.0 g/l), sodium chloride (8.0 g/l) and agar (15 g/l) at a final pH
7.3, were used to growth microorganism. Mueller-Hinton agar (Difco,
France) meat extract (2.0 g/l), acid digest of casein (17.5 g/l), starch
(1.5/l) and agar (17 g/l) at a final pH 7.3 was used in disk diffusion
assays.2.2. Bacterial culture and biofilm formation
K. pneumoniae, isolated from a male patient with recurrent urinary
tract infection (UTI), was selected as representative multidrug resistant
Gram-negative bacteria forming biofilm to mimic surfaces colonized by
bacterial pathogen in hospital environments. The antibiotic suscepti-
bility of this strain was performed by the disk diffusion using standard
antibiotic disks and Mueller-Hinton agar plates (Difco, France) [18].
The antibiotic assayed were: nitrofurantoin (300 μg),
ampicillim-sulbactam (10μg/10μg), ofloxacin (5 μg), norfloxacin (10
μg), ciprofloxacin (5 μg), levofloxacin (5 μg), cephalotin (30 μg), cef-
tazidime (30 μg), gentamicin (10 μg), amikacin (30 μg) and meropenem
(10 μg) (Britania, Argentina). The isolated bacteria were grown in NB at
35 C with shaking (150 rpm) overnight. Then, K. pneumoniae suspen-
sion was adjusted to ~ 106 colony-forming units (CFU) mL1 in fresh
1/10 diluted NB (dNB). Bacterial suspensions were confirmed by viable
count method and used for microbiological assays. Biofilm formation
was carried out on microtiter plates as previously described with minor
modifications [14]. After resuspension in fresh growth medium, ali-
quots of bacterial suspension were added to the wells of sterile
flat-bottom 96-well microtiter test plates (96-well, Greiner Bio-One,
Germany) and incubated for 24 h at 35 C to allow biofilm formation
(24h-biofilm). The wells were washed with sterile distilled water in
order to remove planktonic and sessile cells weakly attached to the
surface. Quantification of viable bacteria in the biofilm was carried out
by serial dilution method and plate counting after their detachment. A
triplicate series of experiments and two replicates were carried out in
each case. These values were used as the “initial number of bacteria in
the biofilm” to which the reduction of viable cells after antimicrobial
treatment was referred.
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The irradiation system employed consists in two tube lamps located
over the samples at 1 cm: a) UV lamp (8 W UV tube, maximum wave-
length 365 nm) and b) white fluorescent (8 W tube, wavelength range
350–750 nm). Biofilms were exposed to both lamps at the same time. Pre-
irradiated PS solutions were irradiated in fluorescence quartz cells of 0.4
cm of path length, at room temperature (distance from the lamp 1 cm). It
is important to highlight that the spectral irradiance of the UV lamp is 31
 4 Wm2, which is lower than the solar spectral irradiance measured at
solar noon (37  4 Wm2) during the spring period [14]. Moreover, the
dose of UV-A radiation used in this work was 14.88 J/cm2 while the
normal minimal erythema dose is greater than 20 J/cm2 [19,20].
Therefore, the UV-A dose applied in this study would be considered safe
for clinical therapy.
2.4. Photodynamic inactivation of biofilm using single and combined
photosensitizers
The antimicrobial effects of aPDT against 24h-biofilm of
K. pneumoniae were evaluated with each PS alone, MB or Cap, and with a
combination of both PSs at a final pH 7.3. The concentration range used
was 2.5μM–10 μM for MB and 100 μM for Cap. When both PSs were
combined solutions were prepared to reach MB/Cap concentrations of
2.5 μM/100 μM, 5 μM/100 μM and 10 μM/100 μM. PSs were added to
pre-existing 24h-biofilms, incubated for 15min in the dark and then were
exposed to radiation during 80 min keeping the temperature at 35 C.
Afterwards, a set of wells treated by aPDT were washed and enumerated
by the plate count method and other identical set remained in darkness at
35 C for 20 h, in order to quantify persisting viable sessile bacteria to
determine if killing action continued during the dark phase (aPDT dark
phase assay).
Control assays experiments were carried out with biofilms grown in
dNB, were performed in triplicate series and with two replicates as
follows:
(1) Dark control: biofilms were kept in darkness after the addition of
Cap or/and MB (radiation-free experiment);
(2) UV þ Vis radiation control: biofilms were incubated in fresh
diluted nutrient broth and irradiated with UV-A and/or visible
radiation for 80 min (PSs-free experiment);
(3) Growth control: biofilms were incubated in fresh diluted nutrient
broth for 80 min (UV þ Vis radiation and PSs free experiment).
The growth control represents the maximum number of sessile
cells expected in biofilms after 80 min growth.
2.5. Statistical analysis
Data were analyzed using one-way analysis of variance (ANOVA) test
to evaluate differences between groups. A p value of <0.05 was consid-
ered statistically significant.
2.6. Analysis of irradiated solutions in microtiter plates
UV-Vis spectrophotometry. Electronic absorption spectra were recor-
ded on a Shimadzu UV-1800 spectrophotometer, using quartz cells of 0.4
cm optical path length. Absorption spectra of the irradiated aqueous or
dNB solutions, containing Cap, MB or Cap/MB, were recorded before and
after irradiation (UV þ Vis radiation during 80 min).
2.7. High-performance liquid chromatography
A high-performance liquid chromatography (HPLC) equipment
Prominence from Shimadzu (solvent delivery module LC-20AT, on-line
degasser DGU-20A5, communications bus module CBM-20, auto sampler
SIL-20A HT, column oven CTO-10AS VP and photodiode array (PDA)3
detector SPD-M20A) was employed for monitoring the reaction. A Luna
C5 column (reverse phase, 5μm, Phenomenex) was used for product
separation. ACN/NH4Ac (pH ¼ 6) were used as mobile phase. A gradient
between 5% to 40% of ACN was used. The flow rate was 0.6 ml/min and
the run time 35 min. The injection volume was 50 μL for all samples. The
simultaneous estimation of Cap and MB was carried out at a detection
wavelength of 346 and 660 nm, respectively. Aqueous solutions of MB
(pH 5), Cap (pH 7.5) and pterin (Ptr) (pH 7.5) standards were employed
to obtain the corresponding calibration curves.
3. Results and discussion
3.1. Inhibition of pre-existing biofilm proliferation and bacterial killing
As model of MDR microorganism it was used a K. pneumoniae strain
exhibiting resistant to multiple antibiotics, such as nitrofurantoin, fluo-
rquinolones (ofloxacin, norfloxacin, ciprofloxacin and levofloxacin),
ampicillin-sulbactam, cephalosporins (cephalotin and ceftazidime),
aminoglycosides (gentamicin). The only efficient antibiotics to eliminate
the current K. pneumoniae strain were meropenem or amikacin. There-
fore, conventional options to fight against this pathogen are limited. As a
consequence, it is observed a high incidence of diseases, frequently in-
hospital urinary tract infections, caused by K. pneumoniae, indicating
that the control of this microorganism deserves the development of
alternative antimicrobial strategies. According to these observations, the
aim of this work is the development of a new and more efficient aPDT.
The combination of two PSs could improve the treatment and therefore,
the use of single PS (MB or Cap) or mixtures of both PSs under irradiation
by UV þ Vis light, in a safe dose for clinical therapy, was evaluated. The
safety of the irradiation and the selection of non-toxic PSs allow the
treatment to be used for disinfection of skin areas under medical
manipulation and not only for disinfection of hospital material.
3.1.1. Direct irradiation of pre-existing biofilm
K. pneumoniae mature biofilms (24 h-biofilms) formed on multiwells
plates and preincubated with Cap (100 μM) or/and MB (2.5, 5 and 10
μM) were exposed to UVþ Vis radiation during 80 min. After irradiation,
the number of viable bacteria was determined immediately (Figure 2a,
green bars). Results showed that for biofilms pre-incubated with Cap
(100 μM) alone the bacterial survival immediately after irradiation was
1.3 log10 and 0.9 log10 lower compared with the initial number of
sessile cells in biofilms (initial inoculums, blue bar) and with UV þ Vis
control, respectively. These values indicate a bacteriostatic action on
K. pneumoniae, as it was previously observed for Staphylococcus aureus
[14]. In the same way, biofilms pre-incubated with MB alone and at
different concentrations (2.5, 5 and 10 μM), were not significantly
affected by the treatment. In addition, these results do not differ signif-
icantly from that observed in the UV þ Vis control. It is important to
remark that the usual concentrations of MB for a typical aPDT treatment
is in the range 20–50 μM [11], higher than the concentrations tested in
this work.
On the other hand, when biofilms were pre-incubated with solutions
containing both Cap and MB the decrease of the viability immediately
after irradiation was improved (Figure 2b). For those samples pre-
incubated with the higher concentration of MB tested (10 μM) in com-
bination with Cap (100 μM), the decrease in viability immediately after
irradiation was at least 3 log10 lower than the initial bacterial number
(bactericidal action). The lowest MB concentrations tested (2.5 μM) in
combination with Cap (100 μM), immediately after irradiation, did not
enhance the antimicrobial action in comparison with Cap pre-incubated
biofilms (p > 0.05). However, after the treatment with MB (10 μM) and
Cap (100 μM) and 80 min of UVþ Vis irradiation, a great increase on the
antimicrobial action was observed (Figure 2b, green bars). The observed
decrease could be defined as synergistic, according to the Bonapace's
criteria [21], since the increase in bacterial killing by the combined aPDT
(MB, 10 μM and Cap 100 μM) was more than 2 log10 in comparison to
Figure 2. aPDT effect with single and mixtures of PSs on biofilms. (a) single
photosensitizer and (b) the mixture Cap þ MB; (green bars) immediately after
irradiation and; (red bars) after irradiation followed by 20 h of dark incubation *
indicates significant differences (p < 0.05) and antimicrobial synergic effect.
Figure 3. Concentrations of Cap (●), MB (▾) and Ptr (■) in irradiated aqueous
solution of Cap þ MB ([Cap] ¼ 100 μM; [MB] ¼ 10 μM) as a function of irra-
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conditions tested, PSs dark toxicity was evaluated, determining the
absence of toxicity under dark incubation, as it was observed in previous
works [14, 22].
After the treatment, biofilms were kept in the dark condition during
20 h (Figure 2b, red bars). Unexpectedly, bacterial cell death was
enhanced for all conditions of combined aPDT. The treatment of biofilms
by irradiation and by a combinedaPDT, with the highest MB concentra-
tion (10 μM) and Cap (100μM), and after 20 h of dark incubation results
in the.early complete killing of bacteria. Thus, an eradication effect for K.
pneumoniae biofilms was achieved. Consequently, a residual antimicro-
bial action improves the total killing action.
3.1.2. Effect of the addition of preirradiated PSs solutions to a pre-existing
biofilm
Taking into account the results described above, the question that
arises is “which process causes bacterial death during the dark incubation
of PS þ UV-Vis pretreated biofilms?” Bacterial killing during 20 h dark
incubation may be a consequence of i) the damage produced during
irradiation, that leads to alterations in metabolic processes that causes
death after the light exposure; or ii) toxic substances formed in the cul-
ture media during irradiation (TS-effect) able to kill cells in the dark. In
this sense, to differentiate these two options, K. pneumoniae biofilms were
pre-incubated with protein (dNB) plus CapþMB solutions and irradiated4
(UV þ Vis) for 80 min. Then immediately after the irradiation was turn
off, the culture media was discarded and replaced by fresh dNB with PSs
and, after that, incubated in the darkness to evaluate possible TS-effect.
These results were compared with pre-irradiated dNB solutions con-
taining Cap þ MB combinations that were added to pre-existing biofilms
of K. pneumoniae as shown in Figure 2b (red bars). Interestingly, this
assay showed that during the dark exposure with fresh dNB plus PSs, the
growth of biofilms samples was not inhibited, and biofilm recovers and
grows, leading to the formation of a new planktonic population (evi-
denced by turbidity in the medium). These results indicate that fresh
media allows bacteria to recuperate, and that combined aPDT does not
markedly affect the bacterial viability. On the contrary, maintaining the
medium after irradiation leads to nearly total killing of cells, indicating
that there is a residual effect of the products of PSs irradiation that in-
hibits the growth of bacteria.
According to these results, it can be noticed that eradication condition
could be achieved by the high antimicrobial action during the aPDT
followed by the dark exposure that allows the action of the residual effect
of the new species generated during irradiation. In this sense, we may
hypothesize that dark phase inhibition may be attributed to: a) the for-
mation of a toxic photo-product/s by reaction with susceptible targets of
excited states of MB and/or Cap during irradiation; and/or b) oxidation
of proteins in the broth medium by both PSs, MB and/or Cap leading to
the consumption of the medium nutrients or the generation of toxic
products for bacteria. To elucidate these hypotheses we performed the
experiments described in the next section.3.2. Analysis of irradiated PSs solutions
3.2.1. Analysis of irradiated solution of PSs
Aqueous solutions containing each PSs alone or combined were
exposed to UV þ Vis irradiation and then analyzed by spectrophotom-
etry and HPLC. Solutions containing both Cap (100 μM) and MB (10
μM) exhibited important changes in the absorption spectra upon irra-
diation. HPLC analysis showed a strong decrease in Cap concentration
and a slight decreased in MB concentration during irradiation
(Figure 3). A new product with higher retention time (tR) was detected
and identified as pterin (Ptr), since the tR and the absorption spectradiation time. Squares (◆) represent the sum of Ptr þ Cap concentrations.
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was expected since it was previously demonstrated that photo-
degradation of Cap yields Ptr [23]. The total concentration of pterins
([Cap] þ [Ptr]) was constant, within the experimental error, indicating
that Cap was quantitatively converted into Ptr. Comparison of the
photolysis of Cap in the presence and in the absence of MB showed that
MB does not affect the photochemistry of Cap. Therefore, it can be
assumed that no additional photo-product emerged as consequence of
reaction between PSs.
3.2.2. Analysis of aqueous solution of Cap þ MB during UV þ Vis
irradiation in the presence of nutrient broth (NB)
Experiments similar to those described in the previous section
(3.1.3), were made with the addition of protein (NB) after and before
UV þ Vis irradiation of Cap þ MB solution ([Cap] ¼ 100 μM and [MB]
¼ 10 μM). The culture medium NB was added to PSs aqueous solutions
to reach the protein content (0.8 mg/ml), corresponding to dNB used
in the microbiological assays. Several changes in the absorption
spectra of the Cap þ MB solutions were observed during irradiation.
Proteins present typical absorption spectra with maximum at 220 and
260 nm, due to peptidic bonds and the presence of aromatic amino-
acids, respectively [24]. When proteins were added to Cap þ MB
aqueous solution that was previously irradiated, the change in the
absorption spectra was limited to a decrease in the intensity at 280 nm,
in comparison with the control (without irradiation) (Figure 4a).
However, a strong absorbance increase in the wavelength range cor-
responding to proteins absorption (230 nm maximum) was observed
when the solution with proteins plus the mixture Cap þ MB was
irradiated, compared with the control condition (without irradiation)
(Figure 4b). These results would indicate that proteins are transformed
together with Cap þ MB photosensitized oxidation that leads to a
nutrient deficiency in the culture media. Consequently, after aPDT
treatment, bacteria damaged by the photosensitized oxidation could
not recover their healthy state due to the protein transformation. All
these events may be considered to interpret the killing action that
continues under dark condition (Figure 2b) that will be analyzed in the
following section.Figure 4. (a) Absorption spectra of mixture of non irradiated proteins and pre-irrad
line); (b) Solution containing proteins and PSs (Cap þ MB), irradiated (dash-dot lin
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3.3. Bacterial damage by aPDT
The mechanisms proposed for bacterial inactivation involve both
direct oxidation (Type I mechanism) of biological targets (lipid mem-
branes, proteins and DNA), and oxidation mediated by singlet oxygen
(1O2) (Type II mechanism). Cap absorbs in the UV-A region (310–400
nm) and MB has strong absorption in the visible region (550–700nm).
Both PSs, under suitable radiation, produces triplet excited states (3Cap*
and 3MB*, respectively) and participates in both type I and type II pho-
tosensitized oxidations [5].
For MB, it has been reported that type I process may be favored by the
binding of positive charged MB to proteins which facilitate protein–MB
electron transfer reactions and formation of PS aggregates [25]. More-
over, type II reactions are amplified in membranes by the binding of PSs
because of the decrease in dimerization of PSs and the increase of oxygen
concentration in the less polar media, which favor the 1O2 yield. On the
other hand, the bactericidal action of Cap under aPDT is attributed also to
both type I and type II mechanisms under UV-A excitation. Interestingly,
the addition of Cap to MB leads to an enhanced killing effect, in agree-
ment with previous results which demonstrated that Cap is efficient in
the prevention of S. aureus growth, either as planktonic cells or as
pre-existing biofilms [14].
Overall, the reduction in the number of viable sessile of K. pneumoniae
observed might be the result of a combination of both photosensitized
mechanisms, that is the participation of 1O2 (type II mechanism) and also
all the chemical reactions derived from both 3Cap* and 3MB* (type I
mechanism), that leads to the injury of different bacterial biological
targets. The combination of two different PSs (Cap þ MB) resulted in a
bactericidal synergic action, and a more efficient use of radiation. In our
opinion, it is possible that each PS acts preferably with a different target,
and that the greater variety of the resulting damaged biomolecules leads
to a condition of difficult recovery for the microorganism. In addition to
the damage caused to the bacteria, the consumption of nutrients neces-
sary for their recovery or the generation of oxidation products causes the
damage to be prolonged preventing bacterial recovery and thus
achieving bacterial eradication and improving the efficiency of the
treatment.iated PSs (Cap þ MB) (dash-dot line) and non-irradiated PSs (Cap þ MB) (solid
e) and non-irradiated (solid line).
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In this work it has been demonstrated that a treatment of aPDT based
on the combination of the photosensitizers (PSs) 6-carboxypterin (Cap)
and methylene blue (MB) is efficient for control, and even eradication, of
multidrug resistant (MDR) K. pneumoniae mature biofilms. Synergistic
effect was observed by combination of the two photosensitizers and,
interestingly, bactericidal activity was exhibited on preexisting mature
biofilm after aPDT treatment followed by overnight-dark incubation. The
results presented in this work, clearly show that a combination of two
known PSs in aPDT treatment, is able to complete the eradication of MDR
bacteria biofilms, unachievable through conventional antimicrobial
treatment or an aPDT treatment mediated by a single PS. Therefore,
although this study was performed in a single strain, the combined aPDT
represents a promising strategy for the disinfection of clinical surfaces
prone to bacterial contamination, indwelling devices and biofouling.
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